Cannara Biotech Inc. (LOVE.V)
CAD 0.68
(0.0%)
CAD 0.68
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 45.78 Million CAD | -5.39% |
| 2022 | 48.39 Million CAD | 131.57% |
| 2021 | 20.89 Million CAD | 61.55% |
| 2020 | 12.93 Million CAD | -2.18% |
| 2019 | 13.22 Million CAD | 1.51% |
| 2018 | 13.02 Million CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 48.65 Million CAD | 6.27% |
| 2024 Q3 | 48.87 Million CAD | -1.15% |
| 2024 Q2 | 49.44 Million CAD | 1.63% |
| 2023 Q1 | 48.2 Million CAD | -0.39% |
| 2023 Q4 | 45.78 Million CAD | 2.78% |
| 2023 FY | 45.78 Million CAD | -5.39% |
| 2023 Q3 | 44.54 Million CAD | 2.72% |
| 2023 Q2 | 43.36 Million CAD | -10.04% |
| 2022 Q2 | 31.22 Million CAD | -0.31% |
| 2022 Q1 | 31.32 Million CAD | 49.88% |
| 2022 FY | 48.39 Million CAD | 131.57% |
| 2022 Q4 | 48.39 Million CAD | 54.66% |
| 2022 Q3 | 31.28 Million CAD | 0.21% |
| 2021 Q4 | 20.89 Million CAD | 26.36% |
| 2021 Q2 | 16.66 Million CAD | 20.88% |
| 2021 FY | 20.89 Million CAD | 61.55% |
| 2021 Q1 | 13.78 Million CAD | 6.56% |
| 2021 Q3 | 16.53 Million CAD | -0.75% |
| 2020 FY | 12.93 Million CAD | -2.18% |
| 2020 Q4 | 12.93 Million CAD | -1.03% |
| 2020 Q3 | 13.06 Million CAD | -0.45% |
| 2020 Q1 | 13.22 Million CAD | -0.01% |
| 2020 Q2 | 13.12 Million CAD | -0.71% |
| 2019 Q4 | 13.22 Million CAD | -0.2% |
| 2019 FY | 13.22 Million CAD | 1.51% |
| 2019 Q3 | 13.25 Million CAD | -0.18% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q2 | 13.27 Million CAD | 0.0% |
| 2018 FY | 13.02 Million CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.06 Million CAD | -804.135% |
| CanadaBis Capital Inc. | 7.3 Million CAD | -526.371% |
| Decibel Cannabis Company Inc. | 40.96 Million CAD | -11.765% |
| Delivra Health Brands Inc. | 2.02 Million CAD | -2158.677% |
| Entourage Health Corp. | 161.58 Million CAD | 71.665% |
| Lifeist Wellness Inc. | 1.26 Million CAD | -3516.336% |
| Medicure Inc. | 544 Thousand CAD | -8316.064% |
| PharmaCielo Ltd. | 18.3 Million CAD | -150.064% |
| Rubicon Organics Inc. | 10.25 Million CAD | -346.251% |
| BioSyent Inc. | 1.22 Million CAD | -3649.525% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -114358.47% |